Protagonist Therapeutics, Inc. (PTGX)
154.72
+0.40
(+0.26%)
USD |
NASDAQ |
Aug 24, 16:00
154.70
-0.02
(-0.01%)
After-Hours: 20:00
Protagonist Therapeutics Gross Profit Margin (Quarterly) : 99.81% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 99.81% |
| March 31, 2026 | 99.28% |
| December 31, 2025 | 94.94% |
| September 30, 2025 | 92.34% |
| June 30, 2025 | 94.52% |
| March 31, 2025 | 99.16% |
| December 31, 2024 | 99.65% |
| September 30, 2024 | 86.16% |
| June 30, 2024 | 78.59% |
| March 31, 2024 | 99.68% |
| December 31, 2023 | 98.61% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 1.86% |
| March 31, 2022 | 96.76% |
| Date | Value |
|---|---|
| December 31, 2021 | 90.50% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 79.81% |
| Insmed, Inc. | 83.71% |
| Madrigal Pharmaceuticals, Inc. | 88.91% |
| AbbVie, Inc. | 74.71% |
| PTC Therapeutics, Inc. | 91.19% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 12.10% |
| Return on Assets | 11.29% |
| Return on Invested Capital | 11.92% |
| Profit Margin (Quarterly) | 76.28% |
| Operating Margin (Quarterly) | 74.37% |
| Return on Net Operating Assets | 229.0% |